News
Tokyo, Japan and Cambridge, UK, 2 May 2025 - Nxera Pharma ("the Company” or "Nxera”; TSE: 4565) provides an update on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback